{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:38:58Z","timestamp":1785425938300,"version":"3.56.0"},"reference-count":29,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 CX002479"],"award-info":[{"award-number":["I01 CX002479"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Increased comorbidities and unique service-related exposures among veterans may contribute to unique tumor biology that can influence tumor behavior and response to treatment. Research that incorporates live cells from veteran donors can support investigation of the genomic and transcriptomic biology of veteran tumors as well as how those molecular alterations affect tumor function, such as growth, metastasis, and treatment sensitivity. We conducted a systematic literature review to assess veteran-focused prostate cancer studies published in the last decade that incorporate live primary cells. We found that in the past 10 years, 105 prostate cancer studies were published that utilized live primary cells from the general population compared with zero studies utilizing live primary cells from veterans. Analysis of veterans enrolled in a study utilizing live primary cells at the William S Middleton Veterans Affairs demonstrated that 94% of veterans who were presented with a live cell biospecimen donation study ultimately enrolled. Furthermore, survey responses from veterans enrolled in this study showed that 83% of veterans found their research engagement to be a meaningful experience and 70% reported increased healthcare satisfaction as a result of their participation. These findings suggest that the lack of live cell prostate cancer research in veterans seems to be due to a lack of research opportunities for veterans and not a lack of veteran interest in participation Finally, we demonstrate that implementation of an informatics-based patient screening strategy can potentially support more veteran-focused studies by reducing participant screening time by 89%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Live primary cells are a unique model for prostate cancer research that provides both molecular and functional readouts to support advances in veteran prostate cancer care. We detail the shortage of live primary research in veterans and address potential barriers to future studies incorporating this model.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0776","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:26:05Z","timestamp":1781112365000},"page":"1522-1530","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying and Addressing Barriers to Live Primary Prostate Cancer Cell Research in Veterans"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0307-4387","authenticated-orcid":false,"given":"Alex","family":"Carlson","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01y2jtd41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Wisconsin-Madison 1 Department of Medicine, , Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0166-9972","authenticated-orcid":false,"given":"Erika","family":"Heninger","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01y2jtd41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Wisconsin-Madison 2 Carbone Cancer Center, , Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6948-0220","authenticated-orcid":false,"given":"Emma E.","family":"Recchia","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01y2jtd41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Wisconsin-Madison 2 Carbone Cancer Center, , Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8239-1953","authenticated-orcid":false,"given":"Joel","family":"Pollen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/037xafn82","id-type":"ROR","asserted-by":"publisher"}],"name":"William S. Middleton Memorial Veterans Hospital 3 , Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2143-7627","authenticated-orcid":false,"given":"Jennifer","family":"Piccolo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/037xafn82","id-type":"ROR","asserted-by":"publisher"}],"name":"William S. Middleton Memorial Veterans Hospital 3 , Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0152-2666","authenticated-orcid":false,"given":"S. Carson","family":"Callahan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/037xafn82","id-type":"ROR","asserted-by":"publisher"}],"name":"William S. Middleton Memorial Veterans Hospital 3 , Madison, Wisconsin."},{"id":[{"id":"https:\/\/ror.org\/01y2jtd41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Wisconsin-Madison 4 Department of Human Oncology, , Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9166-6507","authenticated-orcid":false,"given":"Shuang G.","family":"Zhao","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/037xafn82","id-type":"ROR","asserted-by":"publisher"}],"name":"William S. Middleton Memorial Veterans Hospital 3 , Madison, Wisconsin."},{"id":[{"id":"https:\/\/ror.org\/01y2jtd41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Wisconsin-Madison 4 Department of Human Oncology, , Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8559-6357","authenticated-orcid":false,"given":"David","family":"Kosoff","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01y2jtd41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Wisconsin-Madison 1 Department of Medicine, , Madison, Wisconsin."},{"id":[{"id":"https:\/\/ror.org\/01y2jtd41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Wisconsin-Madison 2 Carbone Cancer Center, , Madison, Wisconsin."},{"id":[{"id":"https:\/\/ror.org\/037xafn82","id-type":"ROR","asserted-by":"publisher"}],"name":"William S. Middleton Memorial Veterans Hospital 3 , Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2026062901043130700_bib1","doi-asserted-by":"crossref","first-page":"e1883","DOI":"10.7205\/MILMED-D-16-00371","article-title":"Cancer incidence among patients of the U.S. Veterans Affairs Health Care System: 2010 update","volume":"182","author":"Zullig","year":"2017","journal-title":"Mil Med"},{"key":"2026062901043130700_bib2","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1158\/1055-9965.EPI-09-0041","article-title":"Cancer incidence in the U.S. military population: comparison with rates from the SEER program","volume":"18","author":"Zhu","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026062901043130700_bib3","first-page":"18m02350","article-title":"US veterans who do and do not utilize Veterans Affairs health care services: demographic, military, medical, and psychosocial characteristics","volume":"21","author":"Meffert","year":"2019","journal-title":"Prim Care Companion CNS Disord"},{"key":"2026062901043130700_bib4","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/cncr.23695","article-title":"Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer","volume":"113","author":"Chamie","year":"2008","journal-title":"Cancer"},{"key":"2026062901043130700_bib5","doi-asserted-by":"crossref","first-page":"e70007","DOI":"10.1002\/cncr.70007","article-title":"Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration","volume":"131","author":"Green-Lott","year":"2025","journal-title":"Cancer"},{"key":"2026062901043130700_bib6","first-page":"17","article-title":"Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety","volume":"13","author":"Botti","year":"2021","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"2026062901043130700_bib7","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/jnci\/djp335","article-title":"Use of archived specimens in evaluation of prognostic and predictive biomarkers","volume":"101","author":"Simon","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2026062901043130700_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/archdischild-2013-304340","article-title":"What is next generation sequencing?","volume":"98","author":"Behjati","year":"2013","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"2026062901043130700_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/bio.2011.0003","article-title":"Integrating collection of biospecimens in clinical trials: the approach of the European organization for research and treatment of cancer","volume":"9","author":"Hall","year":"2011","journal-title":"Biopreserv Biobank"},{"key":"2026062901043130700_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1089\/bio.2014.0009","article-title":"The use of biospecimens in population-based research: a review of the National Cancer Institute\u2019s Division of Cancer Control and Population Sciences grant portfolio","volume":"12","author":"Carrick","year":"2014","journal-title":"Biopreserv Biobank"},{"key":"2026062901043130700_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jclinepi.2015.09.016","article-title":"Million Veteran Program: a mega-biobank to study genetic influences on health and disease","volume":"70","author":"Gaziano","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"Suppl 4","key":"2026062901043130700_bib12","first-page":"S22","article-title":"VA National Precision Oncology Program","volume":"37","author":"Kelley","year":"2020","journal-title":"Fed Pract"},{"issue":"Suppl 4","key":"2026062901043130700_bib13","first-page":"S48","article-title":"The Precision Oncology Program for Cancer of the Prostate (POPCaP) network: a Veterans Affairs\/Prostate Cancer Foundation collaboration","volume":"37","author":"Montgomery","year":"2020","journal-title":"Fed Pract"},{"key":"2026062901043130700_bib14","doi-asserted-by":"crossref","first-page":"11772719221091750","DOI":"10.1177\/11772719221091750","article-title":"The availability of human biospecimens to support biomarker research","volume":"17","author":"Tarling","year":"2022","journal-title":"Biomark Insights"},{"key":"2026062901043130700_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jnci\/djac199","article-title":"Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program","volume":"115","author":"Pagadala","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"2026062901043130700_bib16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/PO.20.00541","article-title":"Polygenic breast cancer risk for women veterans in the Million Veteran Program","volume":"5","author":"Minnier","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"2026062901043130700_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4137\/BIC.S37548","article-title":"The VA point-of-care precision oncology program: balancing access with rapid learning in molecular cancer medicine","volume":"8","author":"Fiore","year":"2016","journal-title":"Biomark Cancer"},{"key":"2026062901043130700_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00428-021-03151-0","article-title":"Basic principles of biobanking: from biological samples to precision medicine for patients","volume":"479","author":"Annaratone","year":"2021","journal-title":"Virchows Arch"},{"key":"2026062901043130700_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2023.04.010","article-title":"Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology\/RTOG 0126 randomized phase 3 trial","volume":"117","author":"Spratt","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026062901043130700_bib20","doi-asserted-by":"crossref","first-page":"EVIDoa2300023","DOI":"10.1056\/EVIDoa2300023","article-title":"Artificial intelligence predictive model for hormone therapy use in prostate cancer","volume":"2","author":"Spratt","year":"2023","journal-title":"NEJM Evid"},{"key":"2026062901043130700_bib21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1553-2712.2010.00866.x","article-title":"Recruitment and retention of patients into emergency medicine clinical trials","volume":"17","author":"Cofield","year":"2010","journal-title":"Acad Emerg Med"},{"key":"2026062901043130700_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/bjc.2014.318","article-title":"Barriers to accrue to clinical trials and possible solutions","volume":"111","author":"Winters","year":"2014","journal-title":"Br J Cancer"},{"key":"2026062901043130700_bib23","doi-asserted-by":"crossref","first-page":"e14185","DOI":"10.2196\/14185","article-title":"A real-time automated patient screening system for clinical trials eligibility in an emergency department: design and evaluation","volume":"7","author":"Ni","year":"2019","journal-title":"JMIR Med Inform"},{"key":"2026062901043130700_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JOP.2012.000646","article-title":"Effort required in eligibility screening for clinical trials","volume":"8","author":"Penberthy","year":"2012","journal-title":"J Oncol Pract"},{"key":"2026062901043130700_bib25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1186\/s12885-019-6181-4","article-title":"Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority","volume":"19","author":"Niedzwiedz","year":"2019","journal-title":"BMC Cancer"},{"key":"2026062901043130700_bib26","doi-asserted-by":"crossref","first-page":"e68676","DOI":"10.2196\/68676","article-title":"Enrollment and retention outcomes from the Veterans Health Administration for a remote digital health study: multisite observational study","volume":"9","author":"Pagliaro","year":"2025","journal-title":"JMIR Form Res"},{"key":"2026062901043130700_bib27","first-page":"1086","article-title":"Matching Patients to Accelerate Clinical Trials (MPACT): enabling technology for oncology clinical trial workflow","volume":"310","author":"Do","year":"2024","journal-title":"Stud Health Technol Inform"},{"key":"2026062901043130700_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.240630502","article-title":"NCI series of cell lines: an historical perspective","volume":"24","author":"Gazdar","year":"1996","journal-title":"J Cell Biochem Suppl"},{"key":"2026062901043130700_bib29","volume-title":"VA Health Care: better data and evaluation could improve community care controls","author":"U.S. Government Accountability Office","year":"2024"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0776\/3803018\/crc-25-0776.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/6\/1522\/3809159\/crc-25-0776.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/6\/1522\/3809159\/crc-25-0776.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:04:41Z","timestamp":1782709481000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/6\/1522\/786315\/Identifying-and-Addressing-Barriers-to-Live"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0776","relation":{},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}